Macclesfield ophthalmics provider eyes growth during 2023

Macclesfield-based Spectrum Ophthalmics has set its sights on growth during 2023, with plans to increase its headcount and product portfolio.

Operating across the UK, the leading independent ophthalmic provider has laid out its plans to increase annual turnover by more than 15% in the next 12 months, a year after becoming part of pan-European healthcare brand AddVision.

Spectrum works with both the NHS and private sector helping surgeons, optometrists and ophthalmologists deliver the best possible care for their patients.

Focussed on becoming the go-to provider in the sector, the fast-growing company has launched a number of new products including a dynamic operating chair, premium intraocular lenses and range of dry eye solutions aimed at meeting new needs from both B2B and B2C user groups.

Managing director at Spectrum Ophthalmics, David Killengray (pictured), commented:

“At some point in our lifetime, most of us will experience impaired vision affecting the day-to-day quality of our lives.  At Spectrum, we are committed to providing eyecare specialists with the absolute best ophthalmic products and solutions that enable them to be more successful and help more patients to enjoy better vision.

“Over the next 12 months we will continue to invest in our product range, unique support solutions and experienced team to provide ophthalmologists with the confidence to deliver the best eyecare solutions, treatments, advice and aftercare for their patients.”

Based in Macclesfield, Spectrum Ophthalmics is a leading provider of ophthalmic products, equipment and solutions that help advance ophthalmic technology and services within the UK.